Search PubMed⌕ Search

Biomedical subjects

E Stein

Publications and source records attributed to E Stein.

At least 217 records · Page 12Linked to original sources
PubMedDate not supplied

Peer review in a New York chapter of the ACNM 1987-1994.

This article is an overview of peer review in Region 2, Chapter 1 (New York City, Nassau, Suffolk, and Westchester counties) of the New York chapter of the American College of Nurse-Midwives from 1987 to 1994. It includes a review of the legal and ethical issues, philosophy, process, standards, and procedure for site review. Problems, findings, and the future of peer review in New York are discussed.

Certification↗
PubMedDate not supplied

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.

This randomized, placebo-controlled, double-masked, parallel-group trial assessed the serum cholesterol-lowering effects of atorvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme. A reductase inhibitor, over 26 weeks in patients with primary hypercholesterolemia. Thirty-nine patients from four centers in the United States were originally randomized to one of two treatment groups and received either atorvastatin 10 mg (20 patients) or placebo (19 patients) once daily. Atorvastatin rapidly and significantly reduced serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B levels. LDL-C was reduced 35% with atorvastatin 10 mg compared with a 0% increase in LDL-C in the placebo group. Atorvastatin significantly reduced triglyceride levels, with improvements occurring over time. At 26 weeks, triglyceride levels were reduced by 21% with atorvastatin treatment compared with a 14% increase with placebo. The drug was well tolerated and no clinically significant laboratory abnormalities were detected.

Adult↗
PubMedDate not supplied

Reducing perinatal transmission of HIV: early diagnosis and interventions during pregnancy.

This article reviews the New York State regulations regarding expedited testing of newborns for exposure to HIV. Included is a review of statistics as well as the medical and obstetric management of HIV positive pregnant women, including route of delivery. The professional responsibility of midwives, physicians, and other clinicians regarding maternal and neonatal health care is emphasized, especially in states without expedited testing.

Female↗